Key facts
- This page summarizes Kapil Dhingra's Form 4 filing for Replimune Group, Inc. (REPL).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 07 Apr 2026, 21:09.
Kapil Dhingra - 01 Apr 2026 Form 4 Insider Report for Replimune Group, Inc. (REPL)
- Reporting relationship
- Director
- Issuer ticker
- REPL
- Reported as of
- 01 Apr 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 07 Apr 2026, 21:09:02 UTC
- Prior SEC filing
- 11 Dec 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Shawn Glidden, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Kapil Dhingra filed Form 4 for Replimune Group, Inc. (REPL) on 07 Apr 2026.
Change
- Previous filing in this sequence was filed on 11 Dec 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001456849
Primary reporting owner
Dhingra Kapil
- Relationship
- Director
- Address
- C/O REPLIMUNE GROUP, INC., 500 UNICORN PARK DRIVE, SUITE 303, WOBURN
- Signature
- /s/ Shawn Glidden, attorney-in-fact
- Signature date
- 07 Apr 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
REPL
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- Shares
- +44,500
- Change %
- Price
- $0.000000*
- Shares after
- 44,500
- Date
- 01 Apr 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 44,500
- Exercise price
- $7.61
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The shares underlying this option vest entirely on April 1, 2027.
SEC remarks
This Form 4 is being filed late due to inadvertent administrative error.